Kenvue CEO Mongon stepping down as company continues with strategic review

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company Kenvue used to be a part of Johnson Johnson J J disclosed in late that it was splitting its consumer wellbeing division from the pharmaceutical and curative device divisions in a bid to make each more nimble Kenvue announced Monday that board member Kirk Perry will serve as interim CEO effective forthwith Perry has served as a director since December and the greater part in recent times served as CEO of Circana a provider of sphere research He spent more than years at Procter Gamble in various roles Kenvue also announced that it is continuing to work with its strategic review committee to explore options for the company The Board s strategic review is underway and we are considering a broad range of feasible alternatives including procedures to simplify the Company s portfolio and how it operates Chair Larry Merlo disclosed in a declaration Kenvue provided chosen preliminary results for its fiscal second quarter The company anticipates adjusted earnings in a range of cents to cents per share Analysts polled by FactSet expect earnings of cents per share Kenvue will description its full quarterly results on Aug and declared that it will revise its full-year outlook on that date Shares rose more than before the area open Source